πŸ‡ΊπŸ‡Έ FDA
Patent

US 11851422

Anti-viral compounds

granted A61KA61K31/4025A61K31/404

Quick answer

US patent 11851422 (Anti-viral compounds) held by Aligos Therapeutics, Inc. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
61
CPC classes
A61K, A61K31/4025, A61K31/404, A61K31/4155, A61K31/4192